95 results
Page 3 of 5
F-3
EX-4.1
zcijg rsol9nsc
7 Dec 23
Shelf registration (foreign)
4:16pm
F-3
EX-4.2
2589th9xe 3tx3o8
7 Dec 23
Shelf registration (foreign)
4:16pm
424B3
9x61mw5n owg2
15 Aug 23
Prospectus supplement
4:52pm
POS AM
0jm 3veanjgyuo2o85
7 Aug 23
Prospectus update (post-effective amendment)
7:56am
6-K
EX-99.1
3lauy3j4
7 Aug 23
NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter 2023 Financial Highlights
7:38am
6-K
EX-99.1
u08d9jsufgyko7ckw
7 Aug 23
Research and development expenses
7:24am
6-K
EX-99.2
qyjdn
7 Aug 23
Research and development expenses
7:24am
424B3
luynim4 8rhwlp
9 Jun 23
Prospectus supplement
9:43pm
6-K
EX-99.1
lonmoj dsxbdrg0
9 Jun 23
Current report (foreign)
9:39pm
6-K
4uqtei
9 Jun 23
Current report (foreign)
9:39pm
6-K
EX-1.1
6r6r78ryto yw6x64
9 Jun 23
Current report (foreign)
9:39pm
424B3
ldapel6z
8 Jun 23
Prospectus supplement
5:01pm
424B3
vmzwc cm13c7uay8nb2y
6 Jun 23
Prospectus supplement
4:20pm
424B3
zldhe
25 Apr 23
Prospectus supplement
8:14am
POS AM
sp66pscx4v88
17 Apr 23
Prospectus update (post-effective amendment)
9:09am
6-K
EX-99.1
v91asswi rc4d
31 Mar 23
NewAmsterdam Pharma Reports Full Year 2022 Financial Results and Provides Corporate Update
8:36am
S-8
EX-99.2
j685dd
31 Mar 23
Registration of securities for employees
7:36am
S-8
EX-5.1
kqf007c8ld8ahi6
31 Mar 23
Registration of securities for employees
7:36am
S-8
EX-99.1
jh86xr9y9 b723
31 Mar 23
Registration of securities for employees
7:36am